tradingkey.logo
tradingkey.logo
Search

AngioDynamics Inc

ANGO
Add to Watchlist
10.770USD
-0.260-2.36%
Close 05/15, 16:00ETQuotes delayed by 15 min
445.00MMarket Cap
LossP/E TTM

AngioDynamics Inc

10.770
-0.260-2.36%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.36%

5 Days

-3.84%

1 Month

+2.96%

6 Months

-11.07%

Year to Date

-16.12%

1 Year

+14.57%

TradingKey Stock Score of AngioDynamics Inc

Currency: USD Updated: 2026-05-15

Key Insights

AngioDynamics Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 44 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 18.67.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

AngioDynamics Inc's Score

Industry at a Glance

Industry Ranking
44 / 206
Overall Ranking
124 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

AngioDynamics Inc Highlights

StrengthsRisks
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Undervalued
The company’s latest PE is -14.20, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 38.82M shares, decreasing 15.68% quarter-over-quarter.
Held by First Eagle Investment
Star Investor First Eagle Investment holds 275.74K shares of this stock.

Analyst Rating

Based on 4 analysts
Buy
Current Rating
18.667
Target Price
+69.24%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

AngioDynamics Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

AngioDynamics Inc Info

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Ticker SymbolANGO
CompanyAngioDynamics Inc
CEOClemmer (James C)
Websitehttps://www.angiodynamics.com/
KeyAI